Medinova Diagnostic Services Yönetim

Yönetim kriter kontrolleri 1/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Sunil Kondapally

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	10.2yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	1.9yrs
Yönetim Kurulu ortalama görev süresi	10yrs

Son yönetim güncellemeleri

Recent updates

CEO

Sunil Kondapally (49 yo)

10.2yrs

Görev süresi

Mr. Sunil Chandra Kondapally serves as Whole time Director at Vijaya Diagnostic Centre Limited since Ocotber 01, 2024. He served as Executive Director at Vijaya Diagnostic Centre Limited until Ocotber 01,...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sunil Kondapally	MD & Director	10.2yrs	Veri yok	Veri yok
Nikhil Jain	Chief Financial Officer	less than a year	Veri yok	Veri yok
Hansraj Rajput	Company Secretary & Compliance Officer	1.9yrs	Veri yok	Veri yok

1.9yrs

Ortalama Görev Süresi

Deneyimli Yönetim: 526301's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sunil Kondapally	MD & Director	10.2yrs	Veri yok	Veri yok
Sura Reddy	Non-Executive Chairman	10.2yrs	Veri yok	Veri yok
Ponnapalli Rao	Independent Non-Executive Director	10yrs	₹18.00k	Veri yok
Birudavolu Vishnu Reddy	Non-Executive Director	5.3yrs	Veri yok	Veri yok
Ravi Reddy Kanamatareddy	Non-Executive Independent Director	less than a year	Veri yok	Veri yok

10.0yrs

Ortalama Görev Süresi

60.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 526301's board of directors are seasoned and experienced ( 10 years average tenure).

Medinova Diagnostic Services Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Medinova Diagnostic Services Limited, Annual General Meeting, Sep 03, 2024

Medinova Diagnostic Services Limited Announces Retirement of Mr. K. V. Ravindra Reddy as Independent Director

Medinova Diagnostic Services Limited Announces Cessation of K. V. Ravindra Reddy as Independent Director

Medinova Diagnostic Services Limited Announces Resignation of Madhava Reddy Beeravelli as Chief Financial Officer, Effective 21 December 2023

Medinova Diagnostic Services Limited, Annual General Meeting, Sep 18, 2023

Medinova Diagnostic Services Limited Approves Appointment of Hansraj Singh as Company Secretary, Effective February 14, 2023

Recent updates

Second quarter 2025 earnings released: EPS: ₹0.50 (vs ₹0.67 in 2Q 2024)

Medinova Diagnostic Services Limited to Report Q2, 2025 Results on Oct 29, 2024

Medinova Diagnostic Services Limited, Annual General Meeting, Sep 03, 2024

First quarter 2025 earnings released: EPS: ₹0.42 (vs ₹0.33 in 1Q 2024)

Medinova Diagnostic Services Limited to Report Q1, 2025 Results on Jul 30, 2024

New minor risk - Share price stability

Vijaya Diagnostic Centre Limited (NSEI:VIJAYA) agreed to acquire remaining 37.86% stake in Medinova Diagnostic Services Limited (BSE:526301) for approximately INR 130 million.

Vijaya Diagnostic Centre Limited (NSEI:VIJAYA) agreed to acquire remaining 37.86% stake in Medinova Diagnostic Services Limited (BSE:526301) for approximately INR 130 million.

Medinova Diagnostic Services Limited Announces Retirement of Mr. K. V. Ravindra Reddy as Independent Director

Full year 2024 earnings released: EPS: ₹2.00 (vs ₹1.67 in FY 2023)

Medinova Diagnostic Services Limited Announces Cessation of K. V. Ravindra Reddy as Independent Director

Medinova Diagnostic Services Limited to Report Q4, 2024 Results on Apr 26, 2024

Now 20% overvalued

Third quarter 2024 earnings released: EPS: ₹0.40 (vs ₹0.24 in 3Q 2023)

Medinova Diagnostic Services Limited to Report Q3, 2024 Results on Jan 31, 2024

Investor sentiment improves as stock rises 17%

Medinova Diagnostic Services Limited Announces Resignation of Madhava Reddy Beeravelli as Chief Financial Officer, Effective 21 December 2023

Investor sentiment improves as stock rises 19%

Second quarter 2024 earnings released: EPS: ₹0.67 (vs ₹0.36 in 2Q 2023)

Investor sentiment improves as stock rises 21%

Medinova Diagnostic Services Limited to Report Q2, 2024 Results on Nov 02, 2023

Medinova Diagnostic Services Limited, Annual General Meeting, Sep 18, 2023

First quarter 2024 earnings released: EPS: ₹0.33 (vs ₹0.30 in 1Q 2023)

Investor sentiment improves as stock rises 22%

Full year 2023 earnings released: EPS: ₹1.67 (vs ₹2.27 in FY 2022)

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 15%

Medinova Diagnostic Services Limited Approves Appointment of Hansraj Singh as Company Secretary, Effective February 14, 2023

Third quarter 2023 earnings released: EPS: ₹0.24 (vs ₹0.36 in 3Q 2022)

Medinova Diagnostic Services Limited to Report Q3, 2023 Results on Feb 01, 2023

Medinova Diagnostic Services Limited Announces Executive Changes

Less than half of directors are independent

Medinova Diagnostic Services Limited Announces Resignation of Anusha Kanumuru as Company Secretary and Compliance Officer

Second quarter 2023 earnings released: EPS: ₹0.36 (vs ₹0.54 in 2Q 2022)

Medinova Diagnostic Services Limited to Report Q2, 2023 Results on Nov 02, 2022

Now 21% undervalued

Now 22% undervalued after recent price drop

Medinova Diagnostic Services Limited to Report Q1, 2023 Results on Jul 27, 2022

Full year 2022 earnings released: EPS: ₹2.27 (vs ₹2.03 in FY 2021)

Medinova Diagnostic Services Limited, Annual General Meeting, Aug 03, 2022

Medinova Diagnostic Services Limited Appoints Anusha Kanumuru as Company Secretary and Compliance Officer

Full year 2022 earnings released: EPS: ₹2.27 (vs ₹2.03 in FY 2021)

Now 20% undervalued after recent price drop

Medinova Diagnostic Services Limited to Report Q4, 2022 Results on May 17, 2022

Less than half of directors are independent

Medinova Diagnostic Services Limited Announces Resignation of Vempala Sri Lakshmi as Company Secretary and Compliance Officer

Less than half of directors are independent

Medinova Diagnostic Services Limited Announces Resignation of Balamba Puranam as Independent Director, Effective February 23, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹0.54 (vs ₹0.67 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS ₹1.03 (vs ₹0.04 loss in 1Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Company Secretary & Compliance Officer has left the company

Full year 2021 earnings released: EPS ₹2.03 (vs ₹0.23 loss in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹0.88 (vs ₹0.03 in 3Q 2020)

Medinova Diagnostic Services Limited to Report Q3, 2021 Results on Feb 12, 2021

Investor sentiment deteriorated over the past week

New 90-day high: ₹25.75

Investor sentiment improved over the past week

Market bids up stock over the past week

New 90-day high: ₹14.75